Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.
- DOI
- 10.1172/jci190646
- Published
- 2026 Sep 1
- Container
- The Journal of clinical investigation
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1172/jci190646,
title = {Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.},
author = {Arnold WD and Jeppesen Morgen J and Thomasen PB and Broch-Lips M and Clark LA and Groennebaek T and Skov M and Winther JB and Ramadan A and Rust PA and Myers JH and Darvishi FB and Dashtmian AR and Fish LA and Chugh D and Bold J and Quiroz J and Hutchison J and Nishimune H and Jones RA and Wang X and Fallon JR and Gillingwater TH and Rich MM and Pedersen TH and Clark BC},
year = {2026},
journal = {The Journal of clinical investigation},
doi = {10.1172/jci190646},
url = {https://doi.org/10.1172/jci190646}
}RIS
TY - JOUR TI - Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition. AU - Arnold WD AU - Jeppesen Morgen J AU - Thomasen PB AU - Broch-Lips M AU - Clark LA AU - Groennebaek T AU - Skov M AU - Winther JB AU - Ramadan A AU - Rust PA AU - Myers JH AU - Darvishi FB AU - Dashtmian AR AU - Fish LA AU - Chugh D AU - Bold J AU - Quiroz J AU - Hutchison J AU - Nishimune H AU - Jones RA AU - Wang X AU - Fallon JR AU - Gillingwater TH AU - Rich MM AU - Pedersen TH AU - Clark BC PY - 2026 JO - The Journal of clinical investigation DO - 10.1172/jci190646 UR - https://doi.org/10.1172/jci190646 ER -
APA
WD, A., J, J. M., PB, T., M, B., LA, C., T, G., M, S., JB, W., A, R., PA, R., JH, M., FB, D., AR, D., LA, F., D, C., J, B., J, Q., J, H., H, N., RA, J., X, W., JR, F., TH, G., MM, R., TH, P., & BC, C. (2026). Neuromuscular junction failure in sarcopenia is linked to NaV1.4 loss and reversed by ClC-1 inhibition.. The Journal of clinical investigation. https://doi.org/10.1172/jci190646
Source records
- pubmed · retrieved 2026-09-25T09:19:42.102Z
- europe-pmc · retrieved 2026-09-25T09:19:42.094Z